🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network

Recruitingn/aAges 18 Years - anyAllUniversity of Milano Bicocca
NCT07165535 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The primary objective of the study is to assess the impact of the organizational model of the hematology center on the quality of life of patients with CML estimated through standardized tools (EORTC QLQ-30, CML24) and through the patient's opinion regarding aspects of the quality of care.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Subjects aged 18 years or older. * Subjects diagnosed with Chronic Myeloid Leukemia. * Subjects diagnosed with CML under care at the hematology outpatient clinics of the 21 REL centers. * Subjects followed at the reference hematology center for a minimum of 6 months. * Freely given informed consent obtained before the start of the study. Exclusion Criteria: * Subjects who have not given consent to participate in the study. * Subjects who do not meet the inclusion criteria.
💊

What it tests

  • Not listed
📍

Where

1 site
Fondazione IRCCS San Gerardo dei Tintori
Monza, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy